维甲酸抗肿瘤活性及其作用机制的研究进展

被引：3

作者：

孙宾 ^{[1
,2
]}

孙宏晨 ^{[2
]}

机构：

[1] 吉林大学口腔医学院

[2] 吉林大学牙发育与颌骨重塑吉林省重点实验室

来源：

口腔医学研究 | 2018年 / 34卷 / 04期

关键词：

维甲酸; 作用机制; 肿瘤;

D O I：

10.13701/j.cnki.kqyxyj.2018.04.005

中图分类号：

R730.5 [肿瘤治疗学];

学科分类号：

100214 [肿瘤学];

摘要：

在正常组织中维甲酸参与调控多种组织干细胞的分化,在人体发育过程中具有重要的作用。并且研究已经证实对于多种肿瘤,维甲酸同样具有抑制肿瘤生长和诱导肿瘤干细胞分化的作用。本文通过结合现有文献,拟阐述维甲酸抗肿瘤活性及其发挥作用的机制,以期为将来的研究提供理论基础。

引用

页码：356 / 358

页数：3

共 10 条

[1]

Co-delivery of all-trans-retinoic acid and doxorubicin for cancer therapy with synergistic inhibition of cancer stem cells.[J].Rong Sun;Yang Liu;Shi-Yong Li;Song Shen;Xiao-Jiao Du;Cong-Fei Xu;Zhi-Ting Cao;Yan Bao;Yan-Hua Zhu;Ya-Ping Li;Xian-Zhu Yang;Jun Wang.Biomaterials.2015,

[2]

Retinoic acid signaling pathways in development and diseases [J].

Das, Bhaskar C. ;

Thapa, Pritam ;

Karki, Radha ;

Das, Sasmita ;

Mahapatra, Sweta ;

Liu, Ting-Chun ;

Torregroza, Ingrid ;

Wallace, Darren P. ;

Kambhampati, Suman ;

Van Veldhuizen, Peter ;

Verma, Amit ;

Ray, Swapan K. ;

Evans, Todd .

BIOORGANIC & MEDICINAL CHEMISTRY, 2014, 22 (02) :673-683

[3]

Retinoic acid signaling and mouse embryonic stem cell differentiation: Cross talk between genomic and non-genomic effects of RA [J].

Rochette-Egly, Cecile .

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS, 2015, 1851 (01) :66-75

[4]

Progress in molecular-based management of differentiated thyroid cancer [J].

Xing, Mingzhao ;

Haugen, Bryan R. ;

Schlumberger, Martin .

LANCET, 2013, 381 (9871) :1058-1069

[5]

Retinoids regulate stem cell differentiation.[J].Lorraine J.Gudas;John A.Wagner.J. Cell. Physiol..2010, 2

[6]

Polycomb Group Protein Displacement and Gene Activation through MSK-Dependent H3K27me3S28 Phosphorylation [J].

Gehani, Simmi Suman ;

Agrawal-Singh, Shuchi ;

Dietrich, Nikolaj ;

Christophersen, Nicolaj Stroyer ;

Helin, Kristian ;

Hansen, Klaus .

MOLECULAR CELL, 2010, 39 (06) :886-900

[7]

Retinoic acid synthesis and signaling during early organogenesis [J].

Duester, Gregg .

CELL, 2008, 134 (06) :921-931

[8]

The Human Tumor Antigen PRAME Is a Dominant Repressor of Retinoic Acid Receptor Signaling.[J].Mirjam T. Epping;Liming Wang;Michael J. Edel;Leone Carlée;Maria Hernandez;René Bernards.Cell.2005, 6

[9]

Retinoic acid and retinoid X receptors are differentially expressed in thyroid cancer and thyroid carcinoma cell lines and predict response to treatment with retinoids [J].